for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

アンジェス株式会社

4563.T

現在値

140.00JPY

変化

-4.00(-2.78%)

出来高

1,599,200

本日のレンジ

138.00

 - 

145.00

52週レンジ

138.00

 - 

426.00

∙ 約20分前の相場を表示しています。

適時開示

Anges And Brickell Biotech Announce A Collaboration Agreement For The Development Of A Novel DNA Vaccine Candidate For COVID-19 In U.S.

Sept 8 (Reuters) - AnGes Inc <4563.T>::ANGES AND BRICKELL BIOTECH ANNOUNCE A COLLABORATION AGREEMENT FOR THE DEVELOPMENT OF A NOVEL DNA VACCINE CANDIDATE FOR COVID-19 IN THE U.S..BRICKELL BIOTECH INC - ANGES WILL CONTINUE TO LEAD DEVELOPMENT OF ITS VACCINE CANDIDATE IN JAPAN.BRICKELL BIOTECH INC - HAS RECEIVED RIGHT TO DEVELOP AND, IF APPROVED, COMMERCIALIZE ANGES' DNA VACCINE IN U.S. AND CERTAIN UNDERSERVED COUNTRIES..

AnGes says exercise of options

Nov 16(Reuters) - AnGes Inc <4563.T>:Says 19,500 units of its 33th series options were exercised to 1,950,000 shares of its common stock from Nov. 15 to Nov. 16.

AnGes says exercise of options

Nov 14(Reuters) - AnGes Inc <4563.T>:Says 21,500 units of its 33th series options were exercised to 2,150,000 shares of its common stock from Nov. 1 to Nov. 14.

AnGes says exercise of options

Oct 30(Reuters) - AnGes Inc <4563.T>:Says 16,300 units of its 33th series options were exercised to 1,630,000 shares of its common stock from Oct. 12 to Oct. 30.

AnGes says exercise of options

Aug 15(Reuters) - AnGes Inc <4563.T>:Says 24,911 units of its 31th series options were exercised to 2.5 million shares of its common stock from Aug. 1 to Aug. 15.

AnGes says exercise of options

July 31 (Reuters) - AnGes Inc <4563.T>:Says 13,372 units of its 31th series options were exercised to 1.3 million shares of its common stock from July 18 to July 31 .

AnGes says joint development with Vasomune Therapeutics

July 30(Reuters) - AnGes Inc <4563.T>:Says it signed contract for joint development of drugs used for acute respiratory insufficiency, with Canada biotechnology firm Vasomune Therapeutics Inc.

AnGes says exercise of options

July 17(Reuters) - AnGes Inc <4563.T>:Says 12,134 units of its 31th series options were exercised to 1.2 million shares of its common stock from July 1 to July 17 .

AnGes says exercise of options

May 31 (Reuters) - AnGes Inc <4563.T>:Says 16,267 units of its 31th series options were exercised to 1.6 million shares of its common stock from May 1 to May 31 .

AnGes submits application for marketing approval for HGF gene therapy

Jan 22 (Reuters) - AnGes Inc <4563.T> ::Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI).

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up